Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:33 AM ET 8-K
Executive Compensation Scientific Industries Inc SCND

Scientific Industries Executive Compensation

Scientific Industries entered into a new employment agreement with CFO Zachary Rovinsky and extended the agreements of CEO Helena Santos and Chairman John A. Moore. Mr. Rovinsky will receive an annual salary of $210,000 through September 2028, while Ms. Santos and Mr. Moore's contracts were extended through September 2027 with salaries of $200,000 and $165,000, respectively.

Term
through Sept 2028
8:30 AM ET 8-K
Business Update Blue Owl Technology Income Corp. OTIC

Blue Owl Technology Income Business Update

Blue Owl Technology Income Corp. (OTIC) provided a shareholder update reporting a 2.1% quarter-to-date total return for Class I shareholders as of August 31, 2026, and a 9.0% annualized total return since inception. The Fund noted stable credit quality with non-accruals at 0.3% of fair value and reported that estimated repurchase requests for the third quarter totaled $1.1 billion (39.0% of shares outstanding), which will be fulfilled on a 5% pro rata basis.

8:30 AM ET 8-K
Business Update Blue Owl Credit Income Corp. OCIC

Blue Owl Credit Income Business Update

Blue Owl Credit Income Corp. provided an operational update reporting that it received $3.1 billion in share repurchase requests for Q3 2026, a decrease from previous quarters. The Fund will fulfill its 5% tender offer on a pro rata basis and highlighted its strong liquidity position of $11.2 billion and resilient credit quality with non-accruals at only 0.2% of fair value.

8:28 AM ET 8-K
Business Update Rivian Automotive, Inc. RIVN

Rivian Automotive Business Update

Rivian reported Q3 2026 production of 19,751 vehicles and deliveries of 19,248 vehicles from its Normal, Illinois facility. The company reaffirmed its full-year 2026 delivery guidance of 65,000 to 70,000 vehicles and scheduled its formal Q3 financial results release for October 29, 2026.

Earnings call
Oct 29, 2026, 5:00 PM ET
8:28 AM ET Form 4
Insider Selling XPO, Inc. XPO

XPO COO David J. Bates Sells $465K of Stock

David J. Bates, COO, sold 2,615 shares of XPO, Inc. at $175.77 to $179.66 a share (average $177.93) in 4 transactions, worth $465K in total on Oct 1, 2026. Shares held after the trade: 62,120 (-1.1%).

Value
$465K
Shares
2,615
Average price
$177.93
Role
COO
Holding change
-1.1%
Trade date
Oct 1, 2026
8:27 AM ET Form 4
Insider Selling XPO, Inc. XPO

XPO CFO Kyle Wismans Sells $132K of Stock

Kyle Wismans, CFO, sold 750 shares of XPO, Inc. at $175.47 a share, worth $132K in total on Oct 1, 2026. Shares held after the trade: 47,966 (-1.5%).

Value
$132K
Shares
750
Price
$175.47
Role
CFO
Holding change
-1.5%
Trade date
Oct 1, 2026
8:20 AM ET 8-K
Business Update Integra Lifesciences Holdings Corp IART

Integra Lifesciences Holdings Business Update

Integra LifeSciences announced preliminary Q3 2026 revenue of $410-$412 million and updated its full-year guidance to reflect a $22-$27 million total revenue impact from flooding at its Cincinnati manufacturing facility. The company expects the facility to return to full operations in Q2 2027 and anticipates insurance recoveries to mitigate a substantial portion of the financial impact.

8:19 AM ET 8-K
Clinical Trial Data Century Therapeutics, Inc. IPSC

Century Therapeutics Clinical Trial Data

Century Therapeutics presented updated nonclinical data for CNTY-813, its iPSC-derived islet replacement therapy for type 1 diabetes, at the EASD 2026 meeting. The data demonstrated sustained glycemic control in diabetic mouse models for over eleven months and confirmed manufacturing consistency across five clinical-scale batches. The company remains on track to submit an IND for CNTY-813 in Q4 2026, with initial clinical data expected in the second half of 2027.

Counterparty
European Association for the Study of Diabetes (EASD)
8:06 AM ET 8-K
Stock Buyback Hyperion Defi, Inc. HYPD

Hyperion Defi Announces $770K Stock Buyback

Hyperion DeFi announced it has repurchased 240,124 common shares at a weighted average price of $3.21 per share and voluntarily repaid its entire $8.6 million legacy debt obligation to Avenue Capital. The company funded the debt retirement using proceeds from HYPE token sales and cash on hand, leaving it with zero long-term debt and approximately $14.5 million in cash and stablecoins.

Value
$770K

“The month of September was very exciting for us, having raised guidance, commencing share buybacks, paid down legacy debt, and announced multiple new businesses. We are grateful for Avenue Capital’s long-term support of the Company in its transformation away from Eyenovia, our legacy biotech brand. With the debt fully repaid, we now have more operational flexibility to scale our onchain DeFi businesses, as well as more flexibility to improve our capital structure for the benefit of HYPD common stockholders.”

Hyunsu Jung, Chief Executive Officer of Hyperion DeFi
8:06 AM ET 8-K
Capital Raise Surrozen, Inc. SRZN

Surrozen Capital Raise of $95.1M

Surrozen announced that the FDA clearance of its IND application for SZN-8141 triggered a second closing milestone under a previously announced private placement. This second tranche is expected to provide approximately $95.1 million in gross proceeds on or about October 20, 2026, to support clinical development and operations.

Value
$95.1M
8:05 AM ET 8-K
Leadership Change Celcuity Inc. CELC

Celcuity Leadership Change

Celcuity Inc. has appointed David W. Gryska to its Board of Directors, effective October 1, 2026, increasing the board size to nine members. Mr. Gryska, a former CFO of Incyte and Celgene, will also serve on the Audit and Compensation Committees. His appointment comes as the company transitions to a commercial-stage entity following its first FDA approval for REVTORPYK.

Counterparty
David W. Gryska
8:05 AM ET 8-K
Loan & Debt Bally's Corp BALY

Bally's $560M Debt Financing with WhiteHawk Capital Partners, LP

Bally's Corporation closed an amended and restated loan agreement providing $400 million in fully funded term loans and $160 million in delayed draw commitments. The financing, led by WhiteHawk Capital Partners, will fund pre-construction costs for the $4.0 billion Bally's Bronx integrated casino project. The project is a major strategic development for the company, expected to feature gaming facilities, a hotel, and an event center by 2030.

Value
$560M
Counterparty
WhiteHawk Capital Partners, LP
8:00 AM ET 8-K/A
M&A Deal OpenWorld, Inc. OPNW

OpenWorld M&A Deal with Open World Ltd.

VerifyMe, Inc. completed its merger with Open World Ltd., with the target surviving as a wholly owned subsidiary and the combined company rebranding as OpenWorld, Inc. In connection with the closing, the company issued 11,686,124 shares of common stock to Legacy OpenWorld equity holders and 300,000 warrants to business partners. The transaction represents a major strategic shift into digital assets and blockchain innovation.

Counterparty
Open World Ltd. (Legacy OpenWorld)
8:00 AM ET Form 4
Insider Buying Compass Therapeutics, Inc. CMPX

Compass Therapeutics CAO Neil Lerner Buys $18.4K of Stock

Neil Lerner, CAO, bought 20,000 shares of Compass Therapeutics, Inc. at $0.92 a share, worth $18.4K in total on Oct 1, 2026. Shares held after the trade: 420,000 (+5.0%).

Value
$18.4K
Shares
20,000
Price
$0.9200
Role
CAO
Holding change
+5.0%
Trade date
Oct 1, 2026
8:00 AM ET 8-K
Shareholder Meeting CNS Pharmaceuticals, Inc. CNSP

CNS Pharmaceuticals Shareholder Meeting

CNS Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 30, 2026, where shareholders elected six directors and ratified MaloneBailey, LLP as the independent auditor. Stockholders also approved an amendment to the 2020 Equity Plan to increase the number of authorized shares by 650,000 and approved executive compensation on an advisory basis.

7:57 AM ET Form 4
Insider Buying Uxin Ltd UXIN

Uxin CEO Kun Dai Buys $12.8K of Stock

Kun Dai, CEO, bought 9,000 shares of Uxin Ltd at $1.42 a share, worth $12.8K in total on Oct 1, 2026. Shares held after the trade: 24,883 (+56.7%).

Value
$12.8K
Shares
9,000
Price
$1.42
Role
CEO
Holding change
+56.7%
Trade date
Oct 1, 2026
7:56 AM ET 8-K
Bankruptcy & Restructuring EchoStar Corp ECHO

EchoStar Bankruptcy & Restructuring

EchoStar's subsidiary DISH DBS Corporation and its filing entities have emerged from Chapter 11 bankruptcy following the confirmation of a joint prepackaged plan of reorganization. The restructuring resulted in a substantial deleveraging of the DISH DBS entities, reducing aggregate outstanding indebtedness by approximately $4.35 billion through debt restructuring and note repayments. In connection with the emergence, the company entered into several supplemental indentures governing its senior secured and unsecured notes due between 2026 and 2029.

Counterparty
DISH DBS Corporation
7:38 AM ET 8-K
M&A Deal Columbus Acquisition Corp COLAU

Columbus Acquisition M&A Deal with WISeSat.Space Holdings Corp.

Columbus Acquisition Corp. (CAC) has completed its business combination with WISeSat.Space Holdings Corp., a space technology company focused on secure satellite communications. Following the closing on October 1, 2026, the combined company's ordinary shares will begin trading on the Nasdaq under the ticker symbol 'SAIQ' on October 2, 2026.

Counterparty
WISeSat.Space Holdings Corp.
7:32 AM ET 8-K/A
Other 8-K Filing Bnb Plus Corp. BNBX

Bnb Plus Other 8-K Filing

BNB Plus Corp. entered into a second amendment to its Registration Rights Agreement with holders of its registrable securities. The amendment removes the company's fixed deadline to file a resale registration statement, replacing it with a 'demand' structure where holders must request a filing, and includes a waiver of any prior non-compliance by the company.

Counterparty
Comstock Multichain Fund and KGPLA Holdings LLC
7:31 AM ET 8-K
Business Update Bnb Plus Corp. BNBX

Bnb Plus Business Update

BNB Plus Corp. announced a strategic transition from a passive digital asset treasury model to an operating company focused on institutional technology infrastructure for blockchain and AI. The company also plans to monetize its LineaRx subsidiary, which specializes in enzymatic DNA manufacturing for genetic medicines.

Counterparty
GlobalStake Infrastructure LLC
7:31 AM ET 8-K
Investor Presentation Cerenome, Inc. CNSY

Cerenome Investor Presentation

Cerenome, Inc. (formerly Plus Therapeutics, Inc.) filed an updated corporate presentation as of September 30, 2026, for use in meetings with investors and analysts. The presentation covers the company's clinical trials, strategic collaborations, and the development of its CNSide platform for genomic testing.

7:30 AM ET 8-K
Leadership Change IRulya Therapeutics Inc. IRLA

Quince Therapeutics Leadership Change

Quince Therapeutics announced the conditional resignations of three board directors (June Bray, David Lamond, and Christopher Senner) and the appointment of four new directors (Catherine Bonuccelli, Leone Patterson, James Valentine, and Drayton Wise). These changes are contingent upon shareholder approval of several proposals at a Special Meeting on October 6, 2026, including a conversion proposal that may result in a change of control. The resignations were not due to any disagreements with the company's operations or policies.

7:06 AM ET 8-K
M&A Deal Columbus Acquisition Corp COLAU

Columbus Acquisition M&A Deal with WISeSat.Space Corp.

Columbus Acquisition Corp extended its business combination deadline from August 22, 2026, to October 22, 2026, by depositing a total of $100,000 into its trust account. The extension fees were split equally between the company's sponsor, Hercules Capital Management VII Corp, and the merger target, WISeSat.Space Corp., with the company issuing promissory notes to cover the contributions.

Counterparty
WISeSat.Space Corp.
Term
through Oct 2026
7:02 AM ET 8-K
Executive Compensation United States Antimony Corp UAMY

United States Antimony Executive Compensation

United States Antimony Corporation entered into a new three-year employment agreement with Gary C. Evans to continue as CEO, effective August 1, 2026. The agreement provides for an annual base salary of $430,000, eligibility for annual performance bonuses, and specified severance payments ranging from 1.5x to 2x salary and bonus in the event of termination without cause or resignation for good reason.

Counterparty
Gary C. Evans
Term
3 years
7:00 AM ET 8-K
Leadership Change United States Antimony Corp UAMY

United States Antimony Leadership Change

United States Antimony Corporation has appointed Shawn P. Winkler as Senior Vice President and Chief Financial Officer on a permanent basis, effective September 30, 2026. He succeeds Richard R. Isaak, whose employment was terminated without cause and not due to any disagreements regarding financial or reporting practices. Mr. Winkler previously served as the company's Interim CFO since May 2026.

7:00 AM ET 8-K
Dividend Alta Equipment Group Inc. ALTG

Alta Equipment Group Dividend

Alta Equipment Group's Board of Directors has declared a quarterly dividend of $625 per share on its 10% Series A Cumulative Perpetual Preferred Stock. This equates to $0.625 per Depositary Share, payable on October 30, 2026, to shareholders of record as of October 15, 2026.

7:00 AM ET 8-K
Business Update Agree Realty Corp ADC

Agree Realty Business Update

Agree Realty Corporation disclosed its weighted-average number of common shares outstanding for the three and nine months ended September 30, 2026. The filing provides specific share counts used for basic and diluted earnings per share calculations, including the dilutive impact of ATM and April 2025 forward equity offerings.

Term
Q3 2026
6:52 AM ET 8-K
M&A Deal Acco Brands Corp ACCO

Acco Brands M&A Deal with GXT Holding B.V.

ACCO Brands Corporation has successfully completed its acquisition of GXT Holding B.V. (known as Trust), a pan-European provider of computer and gaming accessories. The deal expands ACCO's portfolio in PC accessories, gaming, and mobile peripherals across Europe and Latin America.

Counterparty
GXT Holding B.V. (Trust)
6:46 AM ET 8-K
Investor Presentation Nova Minerals Corp NVA

Nova Minerals Investor Presentation

Nova Minerals Corp announced an investor update webinar hosted by RedChip Companies scheduled for October 7, 2026. CEO Christopher Gerteisen will provide updates on the Estelle Gold and Critical Minerals Project in Alaska and the company's progress in establishing a domestic antimony supply chain funded by a $43.4 million U.S. Department of War award.

Counterparty
RedChip Companies
6:46 AM ET 8-K
Loan & Debt Netstreit Corp. NTST

Netstreit $550M Debt Financing with PNC Bank, National Association

NETSTREIT Corp. entered into an amendment with PNC Bank to increase its existing term loan facilities by $150 million and establish a new $400 million delayed draw term loan facility maturing in 2033. The proceeds from the incremental loans were used to repay a $200 million term loan scheduled to mature in February 2028, effectively extending the company's debt maturity profile.

Value
$550M
Counterparty
PNC Bank, National Association
Term
7 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.